{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:52:25Z","timestamp":1766065945697},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T00:00:00Z","timestamp":1264464000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s00066-010-2100-y","type":"journal-article","created":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:06:15Z","timestamp":1264982775000},"page":"63-69","source":"Crossref","is-referenced-by-count":47,"title":["DEGRO Practical Guidelines for Palliative Radiotherapy of Breast Cancer Patients: Brain Metastases and Leptomeningeal Carcinomatosis"],"prefix":"10.1007","volume":"186","author":[{"given":"Petra","family":"Feyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Luise","family":"Sautter-Bihl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfried","family":"Budach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Dunst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wulf","family":"Haase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Harms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Sedlmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Souchon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Wenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,1,26]]},"reference":[{"key":"2100_CR1","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","volume":"363","author":"D. Andrews","year":"2004","unstructured":"Andrews D, Scott C, Sperduto P, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004;363:1665\u201372.","journal-title":"Lancet"},{"key":"2100_CR2","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1200\/JCO.2002.04.140","volume":"20","author":"D. Antonadou","year":"2002","unstructured":"Antonadou D, Paraskevaidis M, Sarris G, et al. Phase II radomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 2002;20:3644\u201350.","journal-title":"J Clin Oncol"},{"key":"2100_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00066-007-1615-3","volume":"183","author":"S.T. Astner","year":"2007","unstructured":"Astner ST, Nieder C, Stock K, et al. Carcinomatous meningitis appearing as acoustic neuromas. Strahlenther Onkol 2007;183:279\u201383.","journal-title":"Strahlenther Onkol"},{"key":"2100_CR4","unstructured":"AWMF online Leitlinien der Deutschen Gesellschaft f\u00fcr Neurologie: Meningeosis neoplastica (\n                    http:\/\/www.uni-duesseldorf.de\/WWW\/AWMF\/ll\/030-060.htm\n                    \n                  )."},{"key":"2100_CR5","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","volume":"22","author":"J.S. Barnholtz-Sloan","year":"2004","unstructured":"Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004;22:2865\u201372.","journal-title":"J Clin Oncol"},{"key":"2100_CR6","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1","volume":"82","author":"F. Bokstein","year":"1998","unstructured":"Bokstein F, Lossos A, Siegal T. Leptomeningeal metastases from solid tumor: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer 1998;82:1756\u201363.","journal-title":"Cancer"},{"key":"2100_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1212\/WNL.55.1.117","volume":"55","author":"W. Boogerd","year":"2000","unstructured":"Boogerd W, Dorresteijn LD, van der Sande JJ, et al. Response of leptomeningeal metastases from breast cancer to hormonal therapy. Neurology 2000;55:117\u20139.","journal-title":"Neurology"},{"key":"2100_CR8","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/1097-0142(19910315)67:6<1685::AID-CNCR2820670635>3.0.CO;2-M","volume":"67","author":"W. Boogerd","year":"1991","unstructured":"Boogerd W, Hart AA, van der Sande JJ, et al. Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer 1991;67:1685\u201395.","journal-title":"Cancer"},{"key":"2100_CR9","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.ejca.2004.08.012","volume":"40","author":"W. Boogerd","year":"2004","unstructured":"Boogerd W, van den Bent MJ, Koehler PJ, et al. The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study. Eur J Cancer 2004;40:2726\u201333.","journal-title":"Eur J Cancer"},{"key":"2100_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0360-3016(80)90195-9","volume":"6","author":"B. Borgelt","year":"1980","unstructured":"Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastasis: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980;6:1\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2100_CR11","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/0360-3016(81)90184-X","volume":"7","author":"B. Borgelt","year":"1981","unstructured":"Borgelt B, Gelber R, Larson M, et al. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981;7:1633\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2100_CR12","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1200\/JCO.2005.01.131","volume":"23","author":"M.C. Chamberlain","year":"2005","unstructured":"Chamberlain MC. Neoplastic meningitis. J Clin Oncol 2005;23:3605\u201313.","journal-title":"J Clin Oncol"},{"key":"2100_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1634\/theoncologist.2008-0138","volume":"13","author":"M.C. Chamberlain","year":"2008","unstructured":"Chamberlain MC. Neoplastic meningitis. Oncologist 2008;13:967\u201377.","journal-title":"Oncologist"},{"key":"2100_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/archneurol.2008.506","volume":"66","author":"M.C. Chamberlain","year":"2009","unstructured":"Chamberlain MC, Johnston SK, Glantz MJ. Neoplastic meningitis-related prognostic significance of the Karnofsky performance status. Arch Neurol 2009;66:74\u20138.","journal-title":"Arch Neurol"},{"key":"2100_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1023\/A:1005803918194","volume":"35","author":"M.C. Chamberlain","year":"1997","unstructured":"Chamberlain MC, Kormanik PR. Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy. J Neurooncol 1997;35:55\u201364.","journal-title":"J Neurooncol"},{"key":"2100_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11912-003-0083-x","volume":"5","author":"E.L. Chang","year":"2003","unstructured":"Chang EL, Maor MH. Standard and novel radiotherapeutic approaches to neoplastic meningitis. Curr Oncol Rep 2003;5:24\u20138.","journal-title":"Curr Oncol Rep"},{"key":"2100_CR17","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1002\/cncr.11449","volume":"97","author":"B.F. Cole","year":"2003","unstructured":"Cole BF, Glantz MJ, Jaeckle KA, et al. Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis. Cancer 2003;97:3053\u201360.","journal-title":"Cancer"},{"key":"2100_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1081\/CNV-50458","volume":"23","author":"L.M. DeAngelis","year":"2005","unstructured":"DeAngelis LM, Boutros D. Leptomeningeal metastasis. Cancer Invest 2005;23:145\u201354.","journal-title":"Cancer Invest"},{"key":"2100_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1212\/WNL.39.6.789","volume":"39","author":"L.M. DeAngelis","year":"1989","unstructured":"DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989;39:789\u201396.","journal-title":"Neurology"},{"key":"2100_CR20","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4","volume":"77","author":"K. Fizazi","year":"1996","unstructured":"Fizazi K, Asselain B, Vincent-Salomon A, et al. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen. Cancer 1996;77:1315\u201323.","journal-title":"Cancer"},{"key":"2100_CR21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0360-3016(00)00547-2","volume":"47","author":"L. Gaspar","year":"2000","unstructured":"Gaspar L, Scott C, Murray K, et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000;47:1001\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2100_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","volume":"37","author":"L. Gaspar","year":"1997","unstructured":"Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745\u201351.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2100_CR23","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1002\/1097-0142(19811015)48:8<1749::AID-CNCR2820480810>3.0.CO;2-X","volume":"48","author":"R. Gelber","year":"1981","unstructured":"Gelber R, Larson M, Borgelt B, et al. Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis. Cancer 1981;48:1749\u201353.","journal-title":"Cancer"},{"key":"2100_CR24","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","volume":"54","author":"M. Glantz","year":"2000","unstructured":"Glantz M, Cole B, Forsyth P, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;54:1886\u201393.","journal-title":"Neurology"},{"key":"2100_CR25","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1200\/JCO.1998.16.4.1561","volume":"16","author":"M.J. Glantz","year":"1998","unstructured":"Glantz MJ, Cole BF, Recht L, et al. High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol 1998;16:1561\u20137.","journal-title":"J Clin Oncol"},{"key":"2100_CR26","first-page":"3394","volume":"5","author":"M.J. Glantz","year":"1999","unstructured":"Glantz MJ, Jaeckle KA, Chamberlain MC, et al. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 1999;5:3394\u2013402.","journal-title":"Clin Cancer Res"},{"key":"2100_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","volume":"25","author":"S.A. Grossman","year":"1999","unstructured":"Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev 1999;25:103\u201319.","journal-title":"Cancer Treat Rev"},{"key":"2100_CR28","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ijrobp.2007.01.004","volume":"68","author":"J.P. Hedde","year":"2007","unstructured":"Hedde JP, Neuhaus T, Sch\u00fcller H, et al. A phase I\/II trial of topotecan and radiation therapy for brain metastases in patients with solid tumors. Int J Radiat Oncol Biol Phys 2007;68:839\u201344.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2100_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/PL00002398","volume":"177","author":"B. Hermann","year":"2001","unstructured":"Hermann B, H\u00fcltenschmidt B, Sautter-Bihl ML. Radiotherapy of the neuroaxis for palliative treatment of leptomeningeal carcinomatosis. Strahlenther Onkol 2001;177:195\u20139.","journal-title":"Strahlenther Onkol"},{"key":"2100_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jns.2004.05.008","volume":"223","author":"U. Herrlinger","year":"2004","unstructured":"Herrlinger U, F\u00f6rschler H, K\u00fcker W, et al. Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci 2004;223:167\u201378.","journal-title":"J Neurol Sci"},{"key":"2100_CR31","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1097\/01.pas.0000213306.05811.b9","volume":"30","author":"D.G. Hicks","year":"2006","unstructured":"Hicks DG, Short SM, Prescott NL, et al. Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK 5\/6, and overexpress HER 2 or EGFR. Am J Surg Pathol 2006;30:1097\u2013104.","journal-title":"Am J Surg Pathol"},{"key":"2100_CR32","volume-title":"ICRU report 50: prescribing, recording, and reporting photon beam therapy","author":"International Commission on Radiation UnitsMeasurements.","year":"1993","unstructured":"International Commission on Radiation Units and Measurements. ICRU report 50: prescribing, recording, and reporting photon beam therapy. Washington: International Commission on Radiation Units and Measurements, 1993."},{"key":"2100_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00066-008-1783-9","volume":"184","author":"B.A. Jereczek-Fossa","year":"2008","unstructured":"Jereczek-Fossa BA, Kowalczyk A, D\u2019Onofrio A, et al. Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients. Strahlenther Onkol 2008;184:36\u201340.","journal-title":"Strahlenther Onkol"},{"key":"2100_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11864-001-0073-x","volume":"2","author":"L. Kim","year":"2001","unstructured":"Kim L, Glantz MJ. Neoplastic meningitis. Curr Treat Options Oncol 2001;2:517\u201327.","journal-title":"Curr Treat Options Oncol"},{"key":"2100_CR35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0360-3016(99)00198-4","volume":"45","author":"D. Kondziolka","year":"1999","unstructured":"Kondziolka D, Patel A, Lunsford D, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999;45:427\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2100_CR36","first-page":"951","volume-title":"Radioonkologie, Bd 2: Klinik","author":"R.D. Kortmann","year":"2004","unstructured":"Kortmann RD, Bamberg M. Zentralnervensystem. In: Bamberg M, Molls M, Sack H, Hrsg. Radioonkologie, Bd 2: Klinik. M\u00fcnchen-Wien-New York: Zuckschwerdt, 2004:951\u20131017."},{"key":"2100_CR37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/0360-3016(81)90005-5","volume":"7","author":"J. Kurtz","year":"1981","unstructured":"Kurtz J, Gelber R, Brady L, et al. The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981;7:891\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2100_CR38","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0360-3016(98)00442-8","volume":"43","author":"F. Lagerwaard","year":"1999","unstructured":"Lagerwaard F, Levendag P, Nowak P, et al. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999;43:795\u2013803.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2100_CR39","unstructured":"Leitlinie zur Diagnostik und Therapie der Meningeosis neoplastica der Neuro-Onkologischen Arbeitsgemeinschaft (NOA) und der Arbeitsgemeinschaft Internistische Onkologie (AIO) in der Deutschen Krebsgesellschaft (11\/2005, \n                    http:\/\/www.neuroonkologie.de\/fileadmin\/neuroonkologie\/pdf\/leitmeni.pdf\n                    \n                  )."},{"key":"2100_CR40","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1158\/1078-0432.CCR-08-1080","volume":"15","author":"N.U. Lin","year":"2009","unstructured":"Lin NU, Di\u00e9ras V, Paul D, et al. Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. Clin Cancer Res 2009;15:1452\u20139.","journal-title":"Clin Cancer Res"},{"key":"2100_CR41","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1470::AID-CNCR14>3.0.CO;2-X","volume":"78","author":"A. Mintz","year":"1996","unstructured":"Mintz A, Kestle J, Gaspar L, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996;78:1470\u20136.","journal-title":"Cancer"},{"key":"2100_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3747\/co.2007.129","volume":"14","author":"A. Mintz","year":"2006","unstructured":"Mintz A, Perry J, Spithoff K, et al. Management of single brain metastasis: a practice guideline. Curr Oncol 2006;14:131\u201343.","journal-title":"Curr Oncol"},{"key":"2100_CR43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0360-3016(97)00341-6","volume":"39","author":"K. Murray","year":"1997","unstructured":"Murray K, Scott C, Greenberg H, et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 1997;39:571\u20134.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2100_CR44","unstructured":"NCCN. Clinical practice guidelines in oncology. Central nervous system cancers. V.I\/2008. www.nccn.org"},{"key":"2100_CR45","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0360-3016(02)04379-1","volume":"55","author":"B. Neill","year":"2003","unstructured":"Neill B, Iturria N, Link M, et al. A comparison of surgical resection and sterotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 2003;55:1169\u201376.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2100_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00066-003-1028-x","volume":"179","author":"C. Nieder","year":"2003","unstructured":"Nieder C, Andratschke N, Grosu AL, et al. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases. Strahlenther Onkol 2003;179:16\u201320.","journal-title":"Strahlenther Onkol"},{"key":"2100_CR47","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/0360-3016(94)90558-4","volume":"29","author":"E. Noordijk","year":"1994","unstructured":"Noordijk E, Vecht C, Haaxma-Reiche H, et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 1994;29:711\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2100_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/annonc\/mdn539","volume":"20","author":"I.H. Park","year":"2009","unstructured":"Park IH, Ro J, Lee KS, et al. Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer. Ann Oncol 2009;20:56\u201362.","journal-title":"Ann Oncol"},{"key":"2100_CR49","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jama.280.17.1485","volume":"280","author":"R.A. Patchell","year":"1998","unstructured":"Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases of the brain. JAMA 1998;280:1485\u20139.","journal-title":"JAMA"},{"key":"2100_CR50","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199002223220802","volume":"322","author":"R.A. Patchell","year":"1990","unstructured":"Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494\u2013500.","journal-title":"N Engl J Med"},{"key":"2100_CR51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00066-008-1831-5","volume":"184","author":"D. Rades","year":"2008","unstructured":"Rades D, Dunst J, Schild SE. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 2008;184:251\u20135.","journal-title":"Strahlenther Onkol"},{"key":"2100_CR52","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00066-008-1946-8","volume":"184","author":"D. Rades","year":"2008","unstructured":"Rades D, Kueter J-D, Hornung D, et al. Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT + SRS) for one to three brain metastases. Strahlenther Onkol 2008;184:655\u201362.","journal-title":"Strahlenther Onkol"},{"key":"2100_CR53","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.ijrobp.2008.05.035","volume":"73","author":"D. Rades","year":"2009","unstructured":"Rades D, Kueter J-D, Pluemer A, et al. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases. Int J Radiat Oncol Biol Phys 2009;73:1077\u201381.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2100_CR54","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ejca.2008.10.033","volume":"45","author":"D. Rades","year":"2009","unstructured":"Rades D, Kueter J-D, Veninga T, et al. Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1-3 brain metastases: result of a matched pair analysis. Eur J Cancer 2009;45:400\u20134.","journal-title":"Eur J Cancer"},{"key":"2100_CR55","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1215\/S1152851703000334","volume":"6","author":"L.R. Rogers","year":"2004","unstructured":"Rogers LR, Remer SE, Tejwani S. Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy. Neuro Oncol 2004;6:63\u20134.","journal-title":"Neuro Oncol"},{"key":"2100_CR56","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S0360-3016(01)01622-4","volume":"51","author":"S. Sanghavi","year":"2001","unstructured":"Sanghavi S, Miranpuri S, Chappell R, et al. Radiosurgery for patients with brain metastasis: a multiinstitutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 2001;51:426\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2100_CR57","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00066-007-1811-1","volume":"183","author":"M.L. Sautter-Bihl","year":"2007","unstructured":"Sautter-Bihl ML, Budach W, Dunst J, et al. DEGRO practical guidelines for radiotherapy of breast cancer I. Breast-conserving therapy. Strahlenther Onkol 2007;183:661\u20136.","journal-title":"Strahlenther Onkol"},{"key":"2100_CR58","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00066-008-1901-8","volume":"184","author":"M.L. Sautter-Bihl","year":"2008","unstructured":"Sautter-Bihl ML, Souchon R, Budach W, et al. DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease. Strahlenther Onkol 2008;184:347\u201353.","journal-title":"Strahlenther Onkol"},{"key":"2100_CR59","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/cncr.10541","volume":"15;94","author":"L.J. Schouten","year":"2002","unstructured":"Schouten LJ, Rutten J, Huveneers HA, et al. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002;15;94:2698\u2013705.","journal-title":"Cancer"},{"key":"2100_CR60","first-page":"887","volume-title":"Cancer of the breast","author":"C.B. Shields","year":"2002","unstructured":"Shields CB, Shields LBE, Raque H Jr. Neurologic aspects of breast cancers. In: Donegan WL, Spratt JS, eds. Cancer of the breast, 5th edn. Philadelphia-London-New York-St. Louis-Sydney-Toronto: Saunders, 2002:887\u2013900.","edition":"5th edn."},{"key":"2100_CR61","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0360-3016(02)02770-0","volume":"53","author":"P. Sneed","year":"2002","unstructured":"Sneed P, Suh J, Goetsch S, et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 2002;53:519\u201326.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2100_CR62","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1468-1331.2006.01506.x","volume":"13","author":"R. Soffietti","year":"2006","unstructured":"Soffietti R, Cornu P, Delattre JY, et al. EFNS guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol 2006;13:674\u201381.","journal-title":"Eur J Neurol"},{"key":"2100_CR63","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00066-009-2044-2","volume":"185","author":"R. Souchon","year":"2009","unstructured":"Souchon R, Wenz F, Sedlmayer F, et al. DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer. Bone metastases and metastatic spinal cord compression (MSCC). Strahlenther Onkol 2009;185:417\u201324.","journal-title":"Strahlenther Onkol"},{"key":"2100_CR64","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/cncr.22041","volume":"107","author":"J.-L. Tham","year":"2006","unstructured":"Tham J-L, Sexton K, Kramer R, et al. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 2006;107:696\u2013704.","journal-title":"Cancer"},{"key":"2100_CR65","first-page":"1471","volume":"34","author":"M.N. Tsao","year":"2005","unstructured":"Tsao MN, Lloyd NS, Wong RK, et al. Clinical practice guideline on the optimal radiotherapeutic management of brain metastases. BMC Cancer 2005;34:1471\u20132407\/5\/34.","journal-title":"BMC Cancer"},{"key":"2100_CR66","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ctrv.2005.04.007","volume":"31","author":"M.N. Tsao","year":"2005","unstructured":"Tsao MN, Lloyd NS, Wong RK, et al. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 2005;31:256\u201373.","journal-title":"Cancer Treat Rev"},{"key":"2100_CR67","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/ana.410330605","volume":"33","author":"C. Vecht","year":"1993","unstructured":"Vecht C, Haaxma-Reiche H, Noordijk E, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993;33:583\u201390.","journal-title":"Ann Neurol"},{"key":"2100_CR68","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1212\/WNL.44.4.675","volume":"44","author":"C. Vecht","year":"1994","unstructured":"Vecht C, Hovestadt A, Verbiest H, et al. Dose-effect relationship of dexamethasone on Karnofsky performance in metastasic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day. Neurology 1994;44:675\u201380.","journal-title":"Neurology"},{"key":"2100_CR69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2407-7-53","volume":"7","author":"G.A. Viani","year":"2007","unstructured":"Viani GA, Castilho MS, Salvajoli JV, et al. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems; BMC Cancer 2007;7:53.","journal-title":"BMC Cancer"},{"key":"2100_CR70","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10147-009-0916-1","volume":"14","author":"T. Walbert","year":"2009","unstructured":"Walbert T, Gilbert MR. The role of chemotherapy in the treatment of patients with brain metastases from solid tumors. Int J Clin Oncol 2009;14:299\u2013306.","journal-title":"Int J Clin Oncol"},{"key":"2100_CR71","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"W.R. Wasserstrom","year":"1982","unstructured":"Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982;49:759\u201372.","journal-title":"Cancer"},{"key":"2100_CR72","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0360-3016(95)02156-6","volume":"3","author":"W. Wong","year":"1996","unstructured":"Wong W, Schild S, Sawyer T, et al. Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys 1996;3:585\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-010-2100-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2100-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2100-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2100-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T22:30:58Z","timestamp":1558564258000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-010-2100-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,26]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["2100"],"URL":"https:\/\/doi.org\/10.1007\/s00066-010-2100-y","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,26]]}}}